CHEMOSENSITIVE TRANSFORMED FOLLICULAR NON-HODGKINS-LYMPHOMA (NHL) IS A FIRM-INDICATION FOR HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION - A STUDY FROM THE EBMT REGISTRY
Cd. Williams et al., CHEMOSENSITIVE TRANSFORMED FOLLICULAR NON-HODGKINS-LYMPHOMA (NHL) IS A FIRM-INDICATION FOR HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION - A STUDY FROM THE EBMT REGISTRY, Blood, 88(10), 1996, pp. 2727-2727